Proposed Data Collection Submitted for Public Comment and Recommendations, 84142-84144 [2024-24304]
Download as PDF
<![CDATA[
84142
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Total Burden Hours: 8421
C. Public Comments
A 60-day notice was published in the
Federal Register at 89 FR 59100 on July
22, 2024. Two comments were received.
Comment: One commenter supported
GSA’s use of the CDP Supply Chain
Questionnaire, and further suggested
sharing aggregate information from the
surveys with federal agencies working
on climate change issues; linking GSA’s
efforts with other federal and nonfederal efforts to bolster supply chain
resilience; and considering
administering the survey on a voluntary
basis to large federal grantees such as
state agencies that receive considerable
federal funding.
Response: GSA appreciates this
commenter’s support. GSA already
shares aggregate information from this
survey with other federal agencies and
collaborates with other federal and nonfederal efforts to bolster supply chain
resilience, and expects to continue to do
so. GSA does not administer significant
grants, and notes that CDP Supply
Chain questionnaires were developed
for use by private sector respondents
and are not commonly used by public
sector respondents, which would
increases the potential burdens and
decrease the utility of information
collected from this type of respondents.
Comment: One commenter asserted
that climate change does not exist, and
requested that GSA ‘‘reimburse the
taxpayer for this hoax.’’
Response: The existence and impacts
of climate change, including risks to the
economy and efficiency of federal
procurement and supply chains, are
well supported by the Fifth National
Climate Assessment (‘‘NCA5,’’ https://
nca2023.globalchange.gov), the US
Government’s preeminent report on
climate change impacts, risks, and
responses. The NCA5 was mandated by
Congress in the Global Change Research
Act of 1990 and authored by the U.S.
Global Change Research Program, a
collaboration between at least fifteen
U.S. Federal agencies. The NCA5 was
based on a comprehensive review and
assessment of information sources
determined to meet the standards and
documentation required under the
Information Quality Act and the
Foundations for Evidence-Based
Policymaking Act of 2018, including
peer-reviewed literature, other
literature, Indigenous Knowledge, other
expert and local knowledge, and climate
data processed and prepared for authors
by NOAA’s Technical Support Unit.
NCA5 was thoroughly reviewed by
Federal Government experts, external
experts, and the public multiple times
VerDate Sep<11>2014
16:27 Oct 18, 2024
Jkt 265001
throughout the report development
process. An expert external review was
performed by an ad hoc committee of
the National Academies of Sciences,
Engineering, and Medicine. Even if
climate change were a ‘‘hoax,’’ GSA
lacks authorities or mechanisms for
general reimbursements to taxpayers.
Lois Mandell,
Director, Regulatory Secretariat Division,
General Services Administration.
[FR Doc. 2024–24192 Filed 10–18–24; 8:45 am]
BILLING CODE 6820–14–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–25–25AE; Docket No. CDC–2024–
0078]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled 2024 Marburg Airport Entry
Questionnaires. This information
collection is intended to assess risk for
infection or exposure to Marburg in
travelers coming to the United States
from areas affected by an outbreak of
Marburg originating in Rwanda.
DATES: CDC must receive written
comments on or before December 20,
2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0078 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
2024 Marburg Airport Entry
Questionnaires—New—National Center
for Emerging and Zoonotic Infectious
E:\FR\FM\21OCN1.SGM
21OCN1
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices
lotter on DSK11XQN23PROD with NOTICES1
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Division of Global
Migration Health (DGMH) requests an
Emergency approval for a New
Information Collection Request (ICR).
Section 361 of the Public Health Service
(PHS) Act (42 U.S.C. 264) authorizes the
Secretary of Health and Human Services
(HHS) to make and enforce regulations
necessary to prevent the introduction,
transmission or spread of communicable
diseases from foreign countries into the
United States. Under its delegated
authority, DGMH works to fulfill this
responsibility through a variety of
activities, including the operation of
Port Health Stations at ports of entry
and administration of foreign quarantine
regulations; 42 Code of Federal
Regulation part 71, specifically 42 CFR
71.20 Public Health prevention
measures to detect communicable
disease. This information collection
concerns CDC’s statutory and regulatory
authority related to conducting public
health screening of travelers upon
arrival to the United States and
assessing individual travelers for public
health risk following a report of illness
from a conveyance.
CDC has been tasked with conducting
public health assessments at U.S.
airports of travelers coming from areas
experiencing an outbreak of Marburg
originating in Rwanda. The purpose of
this information collection is to
determine the public health risk that
travelers from areas affected by the 2024
outbreak of Marburg originating in
Rwanda may pose. This information
will be used to: (1) determine if travelers
have symptoms consistent with Marburg
virus disease (MVD) and should be
isolated and medically evaluated upon
arrival in the U.S.; and (2) assist state
and local health departments with
understanding which travelers from the
region may be at higher risk of becoming
ill with MVD and should be prioritized
for taking certain public health
protection measures, such as isolation
or quarantine.
CDC collects international travelers’
contact information under authorities in
the Interim Final Rule: Control of
Communicable Diseases: Foreign
Quarantine and CDC’s Order
Requirement for Airlines and Operators
to Collect and Transmit Designated
Information for Passengers and Crew
VerDate Sep<11>2014
16:27 Oct 18, 2024
Jkt 265001
Arriving Into the United States;
Requirement for Passengers to Provide
Designated Information. Traveler
contact information is sent to CDC
though an existing data-sharing
infrastructure in place between the
United States Department of Homeland
Security (DHS) and HHS/CDC and
approved in OMB Control Number
0920–1354. Contact information for
travelers who have been to an area
affected by the outbreak during the 21
days prior to arrival will be confirmed
at the port of entry. CDC will share
contact information for these travelers
with state and local health departments
so that they can do possible public
health follow up, including public
health assessment of exposure risk and
monitoring for MVD symptoms, and
education to travelers. These public
health interventions will help state and
local health departments determine the
appropriate level of follow needed
based on the traveler’s level of risk and
rapidly identify any travelers with
symptoms that may need to be
prioritized for more targeted public
health measures, such as quarantine,
due to a higher risk of exposure to
Marburg.
To implement the 2024 Marburg
Airport Entry Questionnaires
information collection, CDC will first
require all travelers from designated
areas affected by the 2024 outbreak of
Marburg originating in Rwanda, to
undergo an initial screening to
determine if CDC needs to do further
public health risk assessment or illness
response at the airport. DHS will refer
travelers that have been to designated
areas to another location of the airport
where CDC will ask initial MVD
screening questions. DHS will also
provide the contact information they
have received to CDC electronically as
part of the information collection under
OMB Control Number 0920–1354. CDC
will escort travelers to the area of the
initial MVD screening and confirm with
the traveler that the contact information
on file is correct. CDC will inform DHS
if there are any necessary corrections
needed to the contact information.
In this initial MVD screening setting,
CDC will ask basic questions about signs
or symptoms of illness (e.g., fever, rash,
diarrhea, etc.) or possible exposure (e.g.,
contact with a person sick with MVD,
attendance at a funeral, etc.) as well as
observe travelers to determine if the
traveler is experiencing any overt signs
and symptoms of disease, and measure
their temperature with a noncontact
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
84143
thermometer. If a traveler answers
‘‘Yes’’ to any of these initial screening
questions, is visibly ill, or has a fever,
the traveler will then be referred to
another area of the airport for a public
health risk assessment by CDC. The
public health risk assessment will help
CDC investigate further to determine if
the traveler could be sick with MVD or
to get more information about a possible
exposure to the Marburg virus to
determine if the traveler is high-risk.
The CDC staff member doing the
initial MVD screening will escort the
traveler to the new area of the airport for
further public health risk assessment
questions by other staff members of
CDC. They will indicate the reason the
traveler is being referred for further
public health risk assessment to the new
CDC staff member. Any traveler who is
visibly ill or reports signs or symptoms,
or has an elevated temperature
measurement, will undergo an illness
investigation using the Air Travel
Illness or Death Investigation or
Traveler Follow up Form that is
currently approved under OMB Control
Number 0920–1318. Staff will take
necessary precautions to prevent
possible exposures by any ill travelers,
such as wearing appropriate personal
protective equipment during any illness
investigation.
During the CDC public health risk
assessment, CDC will ask more detailed
questions about possible exposures,
such as symptoms, whether they were
exposed to a person with MVD, and the
nature of contact (e.g., provided direct
health care). Depending on their
symptoms and how they answer, CDC
may refer the person for medical care.
If CDC staff identify any travelers with
high-risk exposures, management will
be coordinated directly with the health
departments of jurisdiction for both the
airport where traveler is located and
their final destination. Issuance of
public health orders under federal or
state authorities may also be considered.
Any information from these public
health risk assessments, as well as
information related to an illness
investigation will be recorded in CDC’s
Port Health Activity Reporting System
(PHARS), which is covered by the
System of Records Notice is 09–20–
0171, Quarantine- and Traveler-Related
Activities.
CDC requests OMB approval for an
estimated 5,110 annual burden hours.
There is no cost to respondents other
than their time to participate.
E:\FR\FM\21OCN1.SGM
21OCN1
84144
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
CDC Initial Screening—Marburg ................................
POE Public Health Risk Assessment Form—CDC
Marburg Response.
43,800
4,380
1
1
5/60
20/60
3,650
1,460
.....................................................................................
....................
........................
....................
5,110
Form name
Traveler ...............................
Traveler ...............................
Total .............................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–24304 Filed 10–18–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[60Day–25–1360; Docket No. CDC–2024–
0077]
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled CryptoNet Case
Report Form. The CryptoNet Case
Report Form will be used by federal,
state, and local public health officials
responsible for conducting interviews
with reported cases of cryptosporidiosis
in their jurisdiction in order to
systematically assess core exposure
elements and risk factors among cases of
cryptosporidiosis.
DATES: CDC must receive written
comments on or before December 20,
2024.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2024–
0077 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
lotter on DSK11XQN23PROD with NOTICES1
16:27 Oct 18, 2024
Jkt 265001
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
FOR FURTHER INFORMATION CONTACT:
Proposed Data Collection Submitted
for Public Comment and
Recommendations
SUMMARY:
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to the
address listed above.
Centers for Disease Control and
Prevention
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of
respondents
Type of respondents
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Total
burden
(in hours)
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
CryptoNet Case Report Form (OMB
Control No. 0920–1360, Exp. 1/31/
2025)—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The Waterborne Disease Prevention
Branch (WDPB) in the Division of
Foodborne, Waterborne, and
Environmental Diseases (DFWED) works
to prevent domestic and global waterrelated diseases. The WDPB is
comprised of five teams, including the
Domestic Waterborne Disease
Epidemiology and Response (WDER)
Team, which focuses on the prevention
and control of waterborne-related
diseases and outbreaks in the United
States. One of the diseases included in
the team’s work is cryptosporidiosis, an
acute diarrheal disease caused by
infection with Cryptosporidium
parasites. The Case Surveillance
Program is a subunit within the
Domestic WDER Team that focuses on
the data collection and management
activities of five waterborne diseases,
including cryptosporidiosis, in the
United States. The Case Surveillance
Program’s current scope of work
includes modernizing data collection
and management, enabling data
connections, and improving public data
access to aid public health action.
CryptoNet is the first molecular
tracking system for Cryptosporidium in
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 89, Number 203 (Monday, October 21, 2024)]
[Notices]
[Pages 84142-84144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24304]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-25-25AE; Docket No. CDC-2024-0078]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled 2024 Marburg Airport Entry
Questionnaires. This information collection is intended to assess risk
for infection or exposure to Marburg in travelers coming to the United
States from areas affected by an outbreak of Marburg originating in
Rwanda.
DATES: CDC must receive written comments on or before December 20,
2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0078 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
2024 Marburg Airport Entry Questionnaires--New--National Center for
Emerging and Zoonotic Infectious
[[Page 84143]]
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration Health (DGMH) requests an Emergency approval for a
New Information Collection Request (ICR). Section 361 of the Public
Health Service (PHS) Act (42 U.S.C. 264) authorizes the Secretary of
Health and Human Services (HHS) to make and enforce regulations
necessary to prevent the introduction, transmission or spread of
communicable diseases from foreign countries into the United States.
Under its delegated authority, DGMH works to fulfill this
responsibility through a variety of activities, including the operation
of Port Health Stations at ports of entry and administration of foreign
quarantine regulations; 42 Code of Federal Regulation part 71,
specifically 42 CFR 71.20 Public Health prevention measures to detect
communicable disease. This information collection concerns CDC's
statutory and regulatory authority related to conducting public health
screening of travelers upon arrival to the United States and assessing
individual travelers for public health risk following a report of
illness from a conveyance.
CDC has been tasked with conducting public health assessments at
U.S. airports of travelers coming from areas experiencing an outbreak
of Marburg originating in Rwanda. The purpose of this information
collection is to determine the public health risk that travelers from
areas affected by the 2024 outbreak of Marburg originating in Rwanda
may pose. This information will be used to: (1) determine if travelers
have symptoms consistent with Marburg virus disease (MVD) and should be
isolated and medically evaluated upon arrival in the U.S.; and (2)
assist state and local health departments with understanding which
travelers from the region may be at higher risk of becoming ill with
MVD and should be prioritized for taking certain public health
protection measures, such as isolation or quarantine.
CDC collects international travelers' contact information under
authorities in the Interim Final Rule: Control of Communicable
Diseases: Foreign Quarantine and CDC's Order Requirement for Airlines
and Operators to Collect and Transmit Designated Information for
Passengers and Crew Arriving Into the United States; Requirement for
Passengers to Provide Designated Information. Traveler contact
information is sent to CDC though an existing data-sharing
infrastructure in place between the United States Department of
Homeland Security (DHS) and HHS/CDC and approved in OMB Control Number
0920-1354. Contact information for travelers who have been to an area
affected by the outbreak during the 21 days prior to arrival will be
confirmed at the port of entry. CDC will share contact information for
these travelers with state and local health departments so that they
can do possible public health follow up, including public health
assessment of exposure risk and monitoring for MVD symptoms, and
education to travelers. These public health interventions will help
state and local health departments determine the appropriate level of
follow needed based on the traveler's level of risk and rapidly
identify any travelers with symptoms that may need to be prioritized
for more targeted public health measures, such as quarantine, due to a
higher risk of exposure to Marburg.
To implement the 2024 Marburg Airport Entry Questionnaires
information collection, CDC will first require all travelers from
designated areas affected by the 2024 outbreak of Marburg originating
in Rwanda, to undergo an initial screening to determine if CDC needs to
do further public health risk assessment or illness response at the
airport. DHS will refer travelers that have been to designated areas to
another location of the airport where CDC will ask initial MVD
screening questions. DHS will also provide the contact information they
have received to CDC electronically as part of the information
collection under OMB Control Number 0920-1354. CDC will escort
travelers to the area of the initial MVD screening and confirm with the
traveler that the contact information on file is correct. CDC will
inform DHS if there are any necessary corrections needed to the contact
information.
In this initial MVD screening setting, CDC will ask basic questions
about signs or symptoms of illness (e.g., fever, rash, diarrhea, etc.)
or possible exposure (e.g., contact with a person sick with MVD,
attendance at a funeral, etc.) as well as observe travelers to
determine if the traveler is experiencing any overt signs and symptoms
of disease, and measure their temperature with a noncontact
thermometer. If a traveler answers ``Yes'' to any of these initial
screening questions, is visibly ill, or has a fever, the traveler will
then be referred to another area of the airport for a public health
risk assessment by CDC. The public health risk assessment will help CDC
investigate further to determine if the traveler could be sick with MVD
or to get more information about a possible exposure to the Marburg
virus to determine if the traveler is high-risk.
The CDC staff member doing the initial MVD screening will escort
the traveler to the new area of the airport for further public health
risk assessment questions by other staff members of CDC. They will
indicate the reason the traveler is being referred for further public
health risk assessment to the new CDC staff member. Any traveler who is
visibly ill or reports signs or symptoms, or has an elevated
temperature measurement, will undergo an illness investigation using
the Air Travel Illness or Death Investigation or Traveler Follow up
Form that is currently approved under OMB Control Number 0920-1318.
Staff will take necessary precautions to prevent possible exposures by
any ill travelers, such as wearing appropriate personal protective
equipment during any illness investigation.
During the CDC public health risk assessment, CDC will ask more
detailed questions about possible exposures, such as symptoms, whether
they were exposed to a person with MVD, and the nature of contact
(e.g., provided direct health care). Depending on their symptoms and
how they answer, CDC may refer the person for medical care. If CDC
staff identify any travelers with high-risk exposures, management will
be coordinated directly with the health departments of jurisdiction for
both the airport where traveler is located and their final destination.
Issuance of public health orders under federal or state authorities may
also be considered. Any information from these public health risk
assessments, as well as information related to an illness investigation
will be recorded in CDC's Port Health Activity Reporting System
(PHARS), which is covered by the System of Records Notice is 09-20-
0171, Quarantine- and Traveler-Related Activities.
CDC requests OMB approval for an estimated 5,110 annual burden
hours. There is no cost to respondents other than their time to
participate.
[[Page 84144]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total
Type of respondents Form name respondents responses per response burden (in
respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Traveler.......................... CDC Initial 43,800 1 5/60 3,650
Screening--Marburg.
Traveler.......................... POE Public Health 4,380 1 20/60 1,460
Risk Assessment
Form--CDC Marburg
Response.
------------------------------------------------------
Total......................... ..................... ........... .............. ........... 5,110
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-24304 Filed 10-18-24; 8:45 am]
BILLING CODE 4163-18-P
